---
title: First Quarter Financial Report
description: Moss, 15 May 2018. Gentian Diagnostics AS announces its results for the first quarter of 2018. Read more:
---

Moss, 15 May 2018

Gentian Diagnostics AS announces its results for the first quarter of 2018. The highlights include

- Record level for total operating revenue of MNOK 11.2 for the quarter
- 100 % growth in sales revenue compared to 1Q17
- 24 % growth in sales revenue compared to 4Q17
- Strong sales for both Cystatin C and fCal
- New Proof-of-Concept announced post end of quarter

Please find the report enclosed. The report will also be made available on [www.gentian.com](https://www.gentian.com).

 

**For further information, please contact:**

Bård Sundrehagen CEO, Gentian Diagnostics   
E-mail: [bard.sundrehagen@gentian.no](mailto:bard.sundrehagen@gentian.no)   
Cell Phone: +47 924 14 117

 

Njaal Kind CFO, Gentian Diagnostics   
E-mail: [njaal.kind@gentian.no](mailto:njaal.kind@gentian.no)   
Cell Phone: +47 919 06 525

 

 

**MeldingsID: ** 451378

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/first-quarter-financial-report#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/first-quarter-financial-report#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/first-quarter-financial-report#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)